EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non–Small Cell Lung Cancers

Arnaud Driussi, Fabien C Lamaze, Manal Kordahi, Victoria Saavedra Armero, Nathalie Gaudreault, Michèle Orain, William Enlow, Chris Abbosh, Darren Hodgson, Abhijit Dasgupta, Andréanne Gagné, Yohan Bossé und 1 weitere

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Arnaud Driussi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation Institut Universitaire de Cardiologie et de Pneumologie de Québec, Santé, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNACarcinoma, Non-Small-Cell LungLung NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellHumansFemaleMaleMiddle AgedAgedNeoplasm StagingDNA MethylationAdultAged, 80 and overEarly Detection of Cancer

Stichwörter der Autor:innen

adenocarcinomablood sheddingcirculating tumor DNAhistologic patternsnon–small cell lung cancersquamous cell carcinoma

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.
  • Translational Medicine Early Oncology, AstraZeneca, Cambridge, United Kingdom.
  • Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Medicine, Université Laval, Quebec City, Canada.
  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Biology, Pathology and Medical Biochemistry, Université Laval, Quebec City, Canada. Elec…

Förderung

  • Fondation Institut Universitaire de Cardiologie et de Pneumologie de Québec
  • Santé
  • AstraZeneca

Zitieren

APA

Driussi, A., Lamaze, F. C., Kordahi, M., Armero, V. S., Gaudreault, N., Orain, M., Enlow, W., Abbosh, C., Hodgson, D., Dasgupta, A., Gagné, A., Bossé, Y., & Joubert, P. (2025). Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non–Small Cell Lung Cancers. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100744

Vancouver

Driussi A, Lamaze FC, Kordahi M, Armero VS, Gaudreault N, Orain M, et al. Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non–Small Cell Lung Cancers. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100744

BibTeX
@article{Driussi2025,
  author = {Driussi, Arnaud and Lamaze, Fabien C and Kordahi, Manal and Armero, Victoria Saavedra and Gaudreault, Nathalie and Orain, Michèle and Enlow, William and Abbosh, Chris and Hodgson, Darren and Dasgupta, Abhijit and Gagné, Andréanne and Bossé, Yohan and Joubert, Philippe},
  title = {Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non–Small Cell Lung Cancers},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100744}
}
Kostenlos starten →